the effects of a combination of recombinant alpha-interferon ( ifn-alpha ) and interleukin-2 ( il-2 ) -activated human killer cells ( lymphokine-activated killer or lak cells ) on hs294t ( ifn-sensitive ) and a375p ( ifn-resistant ) human melanoma cell lines were evaluated .
C0021756
interleukin-2
C0086418
human